|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Randomised clinical trial to determine optimum initiation time of |
| norgestrel-progestin only contraception in Eldoret teaching hospital, Kenya. |
| Were EO; Kendall JZ; Nyongesa P |
| East African Medical Journal. 1997 Feb;74(2):103-7. |
| The optimal time for initiation of progestin-only oral contraception (POC) among fully or nearly fully breast-feeding |
| women was investigated in a comparative study conducted among 200 women delivering at Kenya's Eldoret |
| Teaching Hospital in a 2-year period during 1992-94. 100 women were randomly assigned to initiate POC use at 6 |
| weeks' postpartum (group 1), while the remaining 100 women deferred POC initiation until the onset of menses or 6 |
| postpartum months (whichever event occurred first) (group 2). At 12 months postpartum, 53.57% of mothers in group |
| 1 and 56.67% in group 2 were still taking Ovrette; at 18 months, these rates were 46.10% and 43.59%, respectively. |
| The mean duration of use was 7.6 months in group 1 and 7.5 months in group 2. There were 178 episodes of |
| adverse experiences with Ovrette, 16.9% of which involved menstrual disturbances. Adverse experiences were more |
| likely to be perceived as serious and related to Ovrette in group 1 than in group 2. There were no pregnancies |
| recorded, suggesting that initiation of Ovrette use at 6 months postpartum or when menses reappears is a feasible |
| strategy. However, postpartum women should be provided with counseling on the efficacy of the lactational |
| amenorrhea method. (PubHealth.info Document ID: CONT2T 1030-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Randomised clinical trial to determine optimum initiation |
| time of norgestrel-progestin only contraception in Eldoret teaching hospital, Kenya.", is(are) Were EO; Kendall JZ; |
| Nyongesa P. The source of this article is "East African Medical Journal. 1997 Feb;74(2):103-7.". This article was |
| published in 1997 in English language(s). (PubHealth.info® Document ID: CONT2T 1030-06. All rights reserved with |
| PubHealth.info) PIN: 6030 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
